SPECTRUM PHARMACEUTICALS INC Annual Return On Equity in % from 2012 to 2022

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Spectrum Pharmaceuticals Inc quarterly/annual Return On Equity history and growth rate from 2012 to 2022.
  • Spectrum Pharmaceuticals Inc Return On Equity for the quarter ending March 31, 2023 was -210 %, a 10.1% decline year-over-year.
  • Spectrum Pharmaceuticals Inc annual Return On Equity for 2022 was -198 %, a 11.6% decline from 2021.
  • Spectrum Pharmaceuticals Inc annual Return On Equity for 2021 was -177 %, a 61.7% decline from 2020.
  • Spectrum Pharmaceuticals Inc annual Return On Equity for 2020 was -110 %, a 123% decline from 2019.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2022 -198 -20.6 -11.6% Jan 1, 2022 Dec 31, 2022
2021 -177 -67.6 -61.7% Jan 1, 2021 Dec 31, 2021
2020 -110 -60.5 -123% Jan 1, 2020 Dec 31, 2020
2019 -49.2 -9.8 -24.9% Jan 1, 2019 Dec 31, 2019
2018 -39.4 -4.98 -14.5% Jan 1, 2018 Dec 31, 2018
2017 -34.4 -4.42 -14.7% Jan 1, 2017 Dec 31, 2017
2016 -30 -6.37 -27% Jan 1, 2016 Dec 31, 2016
2015 -23.6 -6.06 -34.6% Jan 1, 2015 Dec 31, 2015
2014 -17.5 +4.15 +19.1% Jan 1, 2014 Dec 31, 2014
2013 -21.7 -56.9 -162% Jan 1, 2013 Dec 31, 2013
2012 35.2 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.